GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OSTO:RAY B) » Definitions » Equity-to-Asset

RaySearch Laboratories AB (OSTO:RAY B) Equity-to-Asset : 0.38 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is RaySearch Laboratories AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. RaySearch Laboratories AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr777 Mil. RaySearch Laboratories AB's Total Assets for the quarter that ended in Mar. 2024 was kr2,064 Mil. Therefore, RaySearch Laboratories AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.38.

The historical rank and industry rank for RaySearch Laboratories AB's Equity-to-Asset or its related term are showing as below:

OSTO:RAY B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.35   Med: 0.57   Max: 0.7
Current: 0.38

During the past 13 years, the highest Equity to Asset Ratio of RaySearch Laboratories AB was 0.70. The lowest was 0.35. And the median was 0.57.

OSTO:RAY B's Equity-to-Asset is ranked worse than
58.74% of 681 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs OSTO:RAY B: 0.38

RaySearch Laboratories AB Equity-to-Asset Historical Data

The historical data trend for RaySearch Laboratories AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB Equity-to-Asset Chart

RaySearch Laboratories AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.54 0.36 0.35 0.38

RaySearch Laboratories AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.36 0.38 0.38 0.38

Competitive Comparison of RaySearch Laboratories AB's Equity-to-Asset

For the Health Information Services subindustry, RaySearch Laboratories AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RaySearch Laboratories AB's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, RaySearch Laboratories AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where RaySearch Laboratories AB's Equity-to-Asset falls into.



RaySearch Laboratories AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

RaySearch Laboratories AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=735.232/1952.666
=0.38

RaySearch Laboratories AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=776.546/2064.202
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RaySearch Laboratories AB  (OSTO:RAY B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


RaySearch Laboratories AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


RaySearch Laboratories AB (OSTO:RAY B) Business Description

Traded in Other Exchanges
Address
Sveavagen 44, P.O. Box 3297, Stockholm, SWE, 103 65
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.

RaySearch Laboratories AB (OSTO:RAY B) Headlines

No Headlines